Methods and compositions for treating polycystic ovary syndrome

Details Methods and compositions for treating polycystic ovary syndrome Methods and compositions for treating polycystic ovary syndrome

2011-06-14

2011-06-14

Russel, Jeffrey E (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S009800, C514S011700

Reexamination Certificate

active

07960341

ABSTRACT:
The present invention relates to methods of treating polycystic ovary syndrome (PCOS) comprising administering glucagon-like peptide-1 (GLP-1), exendin, and analogs and agonists thereof, to subjects suffering therefrom.

REFERENCES:
patent: 6329403 (2001-12-01), Odaka et al.
patent: 6410513 (2002-06-01), Galloway et al.
patent: 6569901 (2003-05-01), Mogensen et al.
patent: 6610746 (2003-08-01), Fryburg et al.
patent: 7105489 (2006-09-01), Hathaway
patent: 7105490 (2006-09-01), Beeley et al.
patent: 2002/0137666 (2002-09-01), Beeley et al.
patent: 2004/0029784 (2004-02-01), Hathaway
patent: 2004/0029891 (2004-02-01), Ghazzi et al.
patent: 2004/0180824 (2004-09-01), Knudsen
patent: 2004/0266678 (2004-12-01), Beeley et al.
patent: WO 99/07404 (1999-02-01), None
patent: WO 01/04156 (2001-01-01), None
patent: WO 02/085406 (2002-10-01), None
patent: WO 2004/050115 (2004-06-01), None
Ahles, “Toward a New Approach: Primary and Preventive Care of the Woman with Polycystic Ovarian Syndrome”, Primary Care Update OB/Gyns 2000; vol. 7(6): 275-278 (2000).
Balen, “Ovulation Induction for Polycystic Ovary Syndrome”, Human Fertility, vol. 3: 106-111 (2000).
Barbieri, “Introduction of Ovulation in Infertile Woman with Hyperandrongenism and Insulin Resistance”, Am. J. Obstet. Gynecol., vol. 183(6): 1412-1418 (2002).
Ciampelli, “Insulin and Polycsytic Ovary Syndrome: A New Look at an Old Subject”, Gynecol, Endocrinal., vol. 12: 277-292 (1998).
Conway, “Hyperinsulinaemia and Polycsytic Ovary Syndrome”, Human Fertility, vol. 3: 93-95 (2000).
Davison, “New Approaches to Insulin Resistance in Polycystic Ovarian Syndrome”, Current Opinion in Obstetrics and Gynecology, vol. 10: 193-198 (1998).
Ehrmann, “Relation of Functional Ovarian Hyperandrongenism to Non-Insulin Dependent Diabetes Mellitus”, Bailliere's Clinical Obstetrics and Gynecology, vol. 11(2): 335-347 (1997).
Franks, “Polycystic Ovarian Syndrome”, Medical Progess, vol. 333(13): 853-861 (1995).
Franks, et al. “Insulin Action in the Normal and Polycystic Ovary”, Endronicology and Metabolism Clinics in North America, vol. 28(2): 361-378 (1999).
Hadine, et al., “Editorial: Polycystic Ovarian Syndrome—Relationship to Epilepsy and Antiepileptic Drug Therapy”, J. Clin. Endocrinology & Metabolism, vol. 86(7): 2946-2949 (2001).
Hopkinson, et al., “Polycystic Ovarian Syndrome: The Metabolic Syndrome Comes to Gynecology”, BMJ, vol. 317: 329-332, (1998).
Iuorno, et al., “Insulin-Lowering Drugs in Polycystic Ovary Syndrome”, Obstetrics and Gynecology Clinics of North America, vol. 28(1) 153-164 (2001).
Kim, et al., Insulin Sensitizers and Polycystic Ovary Syndrome: Can a Diabetes Medication Treat Infertilty? Fertility and Sterility, vol. 73(6): 1097-1098 (2000).
Legro, “Polycystic Ovary Syndrome: Current and Future Treatment Paradigms”, Am. J. Obstet. Gynecol., vol. 179(6) Part 2: S101-S108 (1998).
Nestler, “Role of Hyperinsulinemia in the Pathogenesis of the Polycystic Ovary Syndrome, and Its Clinical Implications”, Seminars in Reproductive Endocrinology, vol. 15(2): 111-112 (1997).
Olefsky, et al., PPARy and the Treatment of Insulin Resistance, TEM, vol. 11(9): 362-367 (2000).
Phipps, “Polycystic Ovary Syndrome and Ovulation Induction”, Obstetrics and Gynecology Clinics of North America, vol. 28(1): 165-182 (2001).
Pugeat, et al., “Insulin Resistance, Polycystic Ovary Syndrome and Metformin”, Drugs, 58 Suppl. vol. 1: 41-46 (1999).
Rosenfield, “Current Concepts of Polycystic Ovary Syndrome”, Balliere's Clinical Obstetrics and Gynecology, vol. 11(2): 307-333 (1997).
Spiegelman, “PPARy in Moncytes: Less Pain, Any Gain?”, Cell, vol. 93: 153-155 (1998).
Udoff, et al. “Polycystic Ovarian Disease: A New Look at an Old Subject”, Current Opinion in Obstetrics and Gynecology, vol. 7: 340-343 (1995).
Utiger, “Insulin and the Polycystic Ovary Syndrome”, The new England Jounral of Medicine, vol. 335(9): 657-658 (1996).
Wolf, “Ovulation Induction”, Clinical Obstetrics and Gynecology, vol. 43(4): 902-915 (2000).
Zacur, “Polycystic Ovary Syndrome, Hyperandrongeism, and Insulin Resistance”, Obstetrics and Gynecology Clinics of North America, vol. 28(1): 21-33 (2001).

Affiliated with

Also associated with

Rating

Methods and compositions for treating polycystic ovary syndrome does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and compositions for treating polycystic ovary syndrome, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for treating polycystic ovary syndrome will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2645810